CSN Login
Members Online: 8

You are here

Announcements

Have an announcement? Complete and submit an announcement submission request form. Announcements are selected based on relevance and available space. Selection does not imply endorsement by the American Cancer Society.

Monday, May 2, 2016 - 7:56pm

Research study, clinical trial, writer/journalist request,focus group,etc

Tuesday, November 1, 2016 - 8:00pm

Researchers from Memorial University are recruiting young adult cancer survivors for an online study consisting of a health survey. The survey takes approximately 20 to 40 minutes to complete. Participants who complete the survey will be entered into a lottery draw for a prize pack, which includes a Fitbit!

If you are a young adult cancer survivor between the ages of 18 and 39 and are interested in helping researchers collect valuable information, please visit the following link:

www.surveymonkey.com/r/YACSsedentarybehaviour

Similarly, if you know of any young adult cancer survivors who would be interested in participating in this study, please direct them to the above link!

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Ryan Collins
u32rhc@mun.ca
Monday, February 29, 2016 - 2:12pm

Research study, clinical trial, writer/journalist request,focus group,etc

University of Iowa researchers are looking for individuals 18 and older who are currently undergoing treatment for colorectal cancer and their spouses who are interested in being in a study on message processing and support in the cancer experience. Couples will be entered into a drawing to receive one of ten $50 checks. Information is confidential. Please email Ariana Shahnazi at ariana-shahnazi@uiowa.edu or call 818-314-4696 for more information.

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

 

For more information, contact:
Ariana Shahnazi
818-314-4696
ariana-shahnazi@uiowa.edu
Wednesday, February 24, 2016 - 11:17pm

Research study, clinical trial, writer/journalist request,focus group,etc

Wednesday, February 24, 2016 - 11:15pm

A study to bank blood and tissue samples for future evaluation to identify genetic mutations and other biomarkers that predispose inflammatory bowel disease (IBD) patients to developing Hepatosplenic T-Cell Lymphoma (HSTCL). Samples will be obtained from patients who have Crohn's Disease (CD) or Ulcerative Colitis (UC), who have been treated with adalimumab and diagnosed with HSTCL. 

Inclusion Criteria:

1. Male or female who has received a single dose of HUMIRA prior to a confirmed diagnosis of HSTCL.

2. Confirmed diagnosis of CD or UC as documented by a Gastroenterologist or physician who diagnosed the CD or UC.

3. Confirmed diagnosis of HSTCL as determined by a biopsy performed on a specimen taken from the patient.

4. Patients 18 years old and older must voluntarily sign and date an IRB/EC approved Informed Consent Form. For patients younger than 18 years old, a parent or legal guardian is required to voluntarily sign and date an IRB/EC approved Informed Consent Form. Pediatric patients will be included in all discussions if possible, in order to obtain their assent.

Exclusion Criteria:

1.  Male or female who has not received at least a single dose of adalimumab prior to a confirmed diagnosis of HSTCL.

2. Unconfirmed diagnosis of HSTCL, CD or UC, respectively.

3. The patient or the patient's HCP is unwilling to participate in this study. 

4. The parents or legal guardians (in the case of patients younger than 18 years of age), who are unable and/or unwilling to consent to the patient's participation in this study.

 

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contact provided below. 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Andrea Byars
847-937-7904
andrea.byars@abbvie.com
Friday, December 4, 2015 - 8:11pm

Research study, clinical trial, writer/journalist request,focus group,etc

Thursday, September 3, 2015 - 2:30pm

We are seeking individuals treated for head and neck cancer to participate in a research study about the impact of head and neck cancer on communication in everyday activities. This study is being conducted by investigators at the University of Washington, but you can participate from home, no matter where you live.

  

Here are the criteria for participating:

> 18 years of age or older

> Ability to speak, read, and write English

> You have had a medical diagnosis and treatment for head and neck cancer (e.g., tongue, throat (pharynx), voicebox (larynx), palate or anywhere in the mouth/oral cavity etc.)

> Are at least 2 years post-treatment for your cancer

> Currently live at home

 

Our study involves filling out questionnaires at 2 time points. The first time point will be when you enroll in the study. The second time point will be about 12 months later. We may also ask to meet with you for a brief interview (not required). Each participant will receive $20 for each packet of questionnaires and/or interview completed. Please visit our website or contact us for more information. This project is funded by the National Institutes of Health (National Cancer Institute).

 

 

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Tanya Eadie
206-616-0312
vocalfx@uw.edu
Thursday, September 3, 2015 - 2:54pm

Research study, clinical trial, writer/journalist request,focus group,etc

Thursday, September 3, 2015 - 2:45pm

We want to hear about your experience with cancer-related cognitive impairment and its impact on communication and participation in everyday activities, including those in the home, at work or school, or in the community. The information you provide will help in counseling patients undergoing treatment for head and neck cancer and in the development of future interventions.

 

Here are the criteria for participating:

· 21 years of age or older

· Ability to speak, read, and write English

· You have had a medical diagnosis and treatment for head and neck cancer (e.g., tongue, throat (pharynx), voicebox (larynx), palate or anywhere in the mouth/oral cavity etc.)

· Experience of cancer-related cognitive impairment (e.g., difficulty concentrating, difficulty finding the right word, feeling of mental fogginess, trouble remembering conversations or lists of words)

· Are at least 1 year post-treatment for your cancer

· Currently live at home

· Live in or near the Seattle/Puget Sound area, or be visiting the area, in order to participate in a face to face interview

 

Participating in our study involves a face to face interview, about 2 hours long, during which we will discuss your experience of changes in memory, thinking, and attention since your diagnosis and treatment for head and neck cancer. We will also discuss the impact of those changes on your ability to communicate, the impact on activities/work/relationships, and what strategies you might have used, whether successful or not, to compensate. In addition, you will be asked to fill out questionnaires that ask about your cognitive function as well as other health symptoms. You don’t have to answer any question that you do not want to answer.

Each participant will receive $30.00 for completing the interview and questionnaires to compensate for their time.

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Susan Bolt
206-616-0312
bolts@uw.edu

Pages